Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article   Aug 02, 2017 | by Dr. Petra Budde, Head of Medical Research, Protagen and Dr Peter Schulz-Knappe, Chief Scientific Officer, Protagen.

 
Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome
 
 
 

RELATED ARTICLES

Henrietta Lacks: The Mother of Modern Medicine

Article

A portrait of Henrietta Lacks has recently been unveiled at the Smithsonian’s National Portrait Gallery, to recognize her life and the vital contributions HeLa cells have made to science.

READ MORE

How Mass Spectrometry Has Changed The Cancer Diagnostics Game

Article

Although histopathology is still the gold standard for diagnosing cancer, molecular analysis using MS has gained traction in recent years for detecting tumors, monitoring progression, and even predicting treatment response.

READ MORE

Advances in Fragment-Based Drug Discovery

Article

Over the past decade, fragment-based drug discovery has garnered increasing interest among drug discovery experts and has established itself as a key approach within the field – acting as an alternative starting point for the discovery of high-quality lead candidates. This article discusses the evolution of FBDD, highlights key drug discoveries, and explores the advantages and challenges of harnessing this approach

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy